Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM‐HF trial

To assess differences in diuretic dose requirements in patients treated with sacubitril/valsartan compared with enalapril in the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure (PARADIGM‐HF) trial.

[1]  M. Domanski,et al.  Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD). , 2003, Journal of the American College of Cardiology.

[2]  S. Solomon,et al.  Elevated plasma renin activity predicts adverse outcome in chronic heart failure, independently of pharmacologic therapy: data from the Valsartan Heart Failure Trial (Val-HeFT). , 2010, Journal of cardiac failure.

[3]  Akshay S. Desai,et al.  Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure. , 2016, Journal of the American College of Cardiology.

[4]  Javed Butler,et al.  The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. , 2009, Journal of the American College of Cardiology.

[5]  G. Felker,et al.  Diuretic Treatment in Heart Failure. , 2017, The New England journal of medicine.

[6]  J. Cohn,et al.  Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis. , 1985, Annals of internal medicine.

[7]  Akshay S. Desai,et al.  Angiotensin-neprilysin inhibition versus enalapril in heart failure. , 2014, The New England journal of medicine.

[8]  R. Schrier,et al.  Cardiorenal syndrome in acute decompensated heart failure. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[9]  M. Domanski,et al.  Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction. , 1999, Circulation.

[10]  M. Domanski,et al.  Diuretic use, progressive heart failure, and death in patients in the DIG study. , 2006, Journal of cardiac failure.

[11]  S. Solomon,et al.  Combined neprilysin and renin-angiotensin system inhibition for the treatment of heart failure. , 2014, JACC. Heart failure.

[12]  J. McMurray,et al.  Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction , 2016, European journal of heart failure.

[13]  M. Gheorghiade,et al.  Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. , 2006, European heart journal.

[14]  C. Brensinger,et al.  Interaction between loop diuretic-associated mortality and blood urea nitrogen concentration in chronic heart failure. , 2011, Journal of the American College of Cardiology.

[15]  Akshay S. Desai,et al.  Health-Related Quality of Life Outcomes in PARADIGM-HF , 2017, Circulation. Heart failure.

[16]  V. Hasselblad,et al.  Loop diuretic dose adjustments after a hospitalization for heart failure: insights from ASCEND‐HF , 2014, European journal of heart failure.